Part 8/10:
Alphabet/Google owns Calico Life Sciences, dedicated to aging research.
Other billionaires like Brian Johnson are investing millions into longevity treatments.
This convergence highlights longevity research as a promising frontier that combines cutting-edge biotech and AI.
The Science Behind the Breakthrough
At the heart of this innovation is the use of Yamanaka factors for cellular reprogramming. These proteins can "reset" adult cells to a pluripotent state—akin to restoring a cell to factory settings. However, challenges with low efficiency have slowed progress. GPT 4B micro’s capabilities could transform the technique, allowing more cells to be reprogrammed rapidly, opening doors to regenerative therapies previously deemed impractical.